Tenaya Therapeutics, Inc. (TNYA)

Latest Insider Confidence Score

2026Q1

42.3
Bearish

Company insider confidence (by quarter)

2021Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Column Group III Gp, Lp 10% Owner 9,400,290 Feb 14, 2024
Column Group III-A, Lp 10% Owner 9,400,290 Feb 14, 2024
Column Group III, Lp 10% Owner 9,400,290 Feb 14, 2024
Column Group Opportunity III, LP 10% Owner 9,400,290 Feb 14, 2024
Column Group Opportunity III GP, LP 10% Owner 9,400,290 Feb 14, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 24, 2026 Feb 26, 2026 COLUMN GROUP III GP, LP 10% Owner Sell 17.5 -4,170,266 -54.29% ✗ $2.4M
Feb 20, 2026 Feb 24, 2026 COLUMN GROUP III GP, LP 10% Owner Sell 20.0 -829,734 -8.76% ✗ $504.8K
Feb 17, 2026 Feb 17, 2026 Higa Tomohiro SVP, Finance Sell 47.5 -3,469 -2.82% ✗ $2.2K
Feb 17, 2026 Feb 17, 2026 Ali Faraz CEO Sell 47.5 -14,862 -3.24% ✗ $9.6K
Feb 17, 2026 Feb 17, 2026 Tingley Whittemore Chief Medical Officer Sell 47.5 -5,160 -2.31% ✗ $3.3K
Feb 10, 2026 Feb 12, 2026 COLUMN GROUP III GP, LP 10% Owner Sell 17.5 -4,400,290 -23.84% ✗ $3M
Feb 3, 2026 Feb 5, 2026 Higa Tomohiro SVP, Finance Neutral 90.0 +29,250 31.13% ✗ -
Feb 3, 2026 Feb 5, 2026 Tingley Whittemore Chief Medical Officer Neutral 90.0 +48,750 27.85% ✗ -
Feb 3, 2026 Feb 5, 2026 Ali Faraz CEO Neutral 90.0 +158,600 52.93% ✗ -
Nov 17, 2025 Nov 17, 2025 Higa Tomohiro SVP, Finance Sell 47.5 -1,367 -1.43% ✗ $1.8K
Nov 17, 2025 Nov 17, 2025 Tingley Whittemore Chief Medical Officer Sell 47.5 -2,877 -1.66% ✗ $3.8K
Nov 17, 2025 Nov 17, 2025 Ali Faraz CEO Sell 47.5 -3,126 -1.03% ✗ $4.2K
Aug 18, 2025 Aug 18, 2025 Higa Tomohiro SVP, Finance Sell 47.5 -2,962 -3.01% ✗ $3.7K
Aug 18, 2025 Aug 18, 2025 Tingley Whittemore Chief Medical Officer Sell 47.5 -5,053 -2.84% ✗ $6.3K
Aug 18, 2025 Aug 18, 2025 Ali Faraz CEO Sell 46.3 -14,533 -4.58% ✗ $18.2K
May 29, 2025 May 30, 2025 Stehman-Breen Catherine Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Walsh Jeffrey T. Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Burroughs Amy L. Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 GOEDDEL DAVID V Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Williams R Sanders Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Srivastava Deepak Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Lee June Director Neutral 52.5 - 0.00% ✗ -
May 29, 2025 May 30, 2025 Parschauer Karah Herdman Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 16, 2025 Higa Tomohiro SVP, Finance Sell 47.5 -1,390 -1.39% ✗ $615.4
May 16, 2025 May 16, 2025 Tingley Whittemore Chief Medical Officer Sell 47.5 -2,937 -1.68% ✗ $1.3K
May 16, 2025 May 16, 2025 Ali Faraz CEO Sell 50.0 -3,189 -0.99% ✗ $1.4K
Mar 10, 2025 Mar 10, 2025 Higa Tomohiro SVP, Finance Sell 47.5 -2,482 -2.43% ✗ $1.3K
Mar 10, 2025 Mar 10, 2025 Tingley Whittemore Chief Medical Officer Sell 47.5 -7,398 -4.06% ✗ $4K
Mar 10, 2025 Mar 10, 2025 Ali Faraz CEO Sell 47.5 -9,741 -2.95% ✗ $5.2K
Mar 5, 2025 Mar 7, 2025 COLUMN GROUP III GP, LP 10% Owner Buy 100.0 +35,714,284 262.62% ✗ $25M
Mar 5, 2025 Mar 7, 2025 GOEDDEL DAVID V Director Buy 100.0 +35,714,284 262.62% ✗ $25M
Feb 7, 2025 Higa Tomohiro SVP, Finance Neutral 52.5 - 0.00% ✗ -
Feb 6, 2025 Feb 7, 2025 Ali Faraz CEO Neutral 90.0 +141,924 75.36% ✗ -
Jan 24, 2025 Jan 28, 2025 Tingley Whittemore Chief Medical Officer Neutral 90.0 +71,676 66.92% ✗ -
Nov 18, 2024 Nov 18, 2024 Saito Chihiro SVP, Accounting and Fin. Ops. Sell 47.5 -2,258 -3.57% ✗ $4.8K
Oct 18, 2024 Oct 21, 2024 Walsh Jeffrey T. Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Williams R Sanders Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Stehman-Breen Catherine Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Srivastava Deepak Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Parschauer Karah Herdman Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Lee June Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 GOEDDEL DAVID V Director Neutral 52.5 - 0.00% ✗ -
Oct 18, 2024 Oct 21, 2024 Burroughs Amy L. Director Neutral 52.5 - 0.00% ✗ -
Aug 15, 2024 Aug 19, 2024 Saito Chihiro SVP, Accounting and Fin. Ops. Sell 90.0 +22,637 55.75% ✗ $6.8K
Aug 19, 2024 Saito Chihiro SVP, Accounting and Fin. Ops. Neutral 52.5 - 0.00% ✗ -
Aug 16, 2024 Aug 16, 2024 Tingley Whittemore Chief Medical Officer Sell 46.3 -7,428 -6.49% ✗ $21.5K
Aug 16, 2024 Aug 16, 2024 Ali Faraz CEO Sell 46.3 -9,748 -4.92% ✗ $28.2K
Mar 5, 2024 Mar 6, 2024 Hoey Timothy Chief Scientific Officer Sell 48.8 -3,300 -1.33% ✓ $23.1K
Feb 23, 2024 Feb 27, 2024 Hoey Timothy Chief Scientific Officer Neutral 85.0 +12,500 5.29% ✗ -
Feb 23, 2024 Feb 27, 2024 Tingley Whittemore Chief Medical Officer Neutral 90.0 +35,000 47.60% ✗ -
Feb 23, 2024 Feb 27, 2024 PATTERSON LEONE D Chief Fin. and Bus. Officer Neutral 90.0 +35,000 57.61% ✗ -
Feb 23, 2024 Feb 27, 2024 Ali Faraz CEO Neutral 90.0 +85,000 75.17% ✗ -
Feb 20, 2024 Feb 21, 2024 Hoey Timothy Chief Scientific Officer Sell 45.0 -6,569 -2.71% ✓ $35K
Feb 16, 2024 Feb 16, 2024 Hoey Timothy Chief Scientific Officer Sell 46.3 -4,681 -1.89% ✗ $27.4K
Feb 16, 2024 Feb 16, 2024 Tingley Whittemore Chief Medical Officer Sell 46.3 -6,500 -8.12% ✗ $38.1K
Feb 16, 2024 Feb 16, 2024 PATTERSON LEONE D Chief Fin. and Bus. Officer Sell 46.3 -5,201 -7.89% ✗ $30.5K
Feb 16, 2024 Feb 16, 2024 Ali Faraz CEO Sell 46.3 -6,358 -5.32% ✗ $37.3K
Feb 12, 2024 Feb 14, 2024 COLUMN GROUP III GP, LP 10% Owner Buy 100.0 +2,222,222 19.53% ✗ $10M
Feb 12, 2024 Feb 14, 2024 GOEDDEL DAVID V Director Buy 100.0 +2,222,222 19.53% ✗ $10M
Aug 29, 2023 Aug 29, 2023 Hoey Timothy Chief Scientific Officer Sell 45.0 -7,243 -2.84% ✓ $30.9K
Aug 16, 2023 Aug 18, 2023 Hoey Timothy Chief Scientific Officer Sell 46.3 -4,007 -1.55% ✗ $15.3K
Aug 16, 2023 Aug 18, 2023 Tingley Whittemore Chief Medical Officer Sell 46.3 -5,563 -6.78% ✗ $21.2K
Aug 16, 2023 Aug 18, 2023 PATTERSON LEONE D Chief Fin. and Bus. Officer Sell 46.3 -4,452 -6.45% ✗ $17K
Aug 16, 2023 Aug 18, 2023 Ali Faraz CEO Sell 46.3 -5,563 -4.45% ✗ $21.2K
Jun 9, 2023 Jun 12, 2023 Walsh Jeffrey T. Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Williams R Sanders Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Stehman-Breen Catherine Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Srivastava Deepak Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Parschauer Karah Herdman Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Lee June Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 GOEDDEL DAVID V Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 CHEN JIN-LONG Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Burroughs Amy L. Director Neutral 52.5 - 0.00% ✗ -
Mar 10, 2023 Mar 14, 2023 COLUMN GROUP III GP, LP 10% Owner Buy 56.3 +6,779 0.06% ✗ $17.6K
Mar 10, 2023 Mar 14, 2023 GOEDDEL DAVID V Director Buy 56.3 +6,779 0.06% ✗ $17.6K
Feb 15, 2023 Feb 17, 2023 Hoey Timothy Chief Scientific Officer Neutral 90.0 +60,000 30.20% ✗ -
Feb 15, 2023 Feb 17, 2023 Tingley Whittemore Chief Medical Officer Neutral 90.0 +80,000 100.00% ✗ -
Feb 15, 2023 Feb 17, 2023 PATTERSON LEONE D Chief Fin. and Bus. Officer Neutral 90.0 +65,000 3250.00% ✗ -
Feb 15, 2023 Feb 17, 2023 Ali Faraz CEO Neutral 90.0 +125,000 100.00% ✗ -
Feb 8, 2023 Feb 10, 2023 COLUMN GROUP III GP, LP 10% Owner Buy 100.0 +1,500,000 15.20% ✗ $3.9M
Feb 8, 2023 Feb 10, 2023 GOEDDEL DAVID V Director Buy 100.0 +1,500,000 15.20% ✗ $3.9M
Jan 19, 2023 Jan 23, 2023 COLUMN GROUP III GP, LP 10% Owner Buy 65.0 +69,739 0.36% ✗ $174.2K
Jan 19, 2023 Jan 23, 2023 GOEDDEL DAVID V Director Buy 65.0 +69,739 0.36% ✗ $174.2K
Jan 17, 2023 Jan 19, 2023 COLUMN GROUP III GP, LP 10% Owner Buy 85.0 +185,151 1.93% ✗ $464.8K
Jan 17, 2023 Jan 19, 2023 GOEDDEL DAVID V Director Buy 85.0 +185,151 1.93% ✗ $464.8K
Nov 21, 2022 Dec 9, 2022 Srivastava Deepak Director Buy 97.5 +230,769 69.23% ✗ $600K
Dec 5, 2022 Dec 7, 2022 Burroughs Amy L. Director Neutral 52.5 - 0.00% ✗ -
Dec 7, 2022 Burroughs Amy L. Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2022 Nov 25, 2022 Casdin Eli Director Buy 100.0 +2,492,042 69.48% ✗ $6.5M
Nov 21, 2022 Nov 23, 2022 COLUMN GROUP III GP, LP 10% Owner Buy 100.0 +9,615,384 100.00% ✗ $25M
Nov 21, 2022 Nov 23, 2022 GOEDDEL DAVID V Director Buy 100.0 +9,615,384 100.00% ✗ $25M
Sep 8, 2022 Sep 9, 2022 Parschauer Karah Herdman Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Walsh Jeffrey T. Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Stehman-Breen Catherine Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Srivastava Deepak Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Lee June Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 GOEDDEL DAVID V Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 CHEN JIN-LONG Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Casdin Eli Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2022 Jun 13, 2022 Williams R Sanders Director Neutral 52.5 - 0.00% ✗ -